Bossiroy Pharma SRL
Bossiroy Pharma reported total assets of 65,695 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Aug 2026).
The score of Bossiroy Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bossiroy Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Aug 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
Bossiroy Pharma's financial analysis
- Solvency91.4%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bossiroy Pharma
Bossiroy Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1004.722.733
- VAT number
- BE1004722733
- Peppol
- Registered · 0208:1004722733 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Jan 2024
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 14 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bossiroy Pharma (SRL) has been based in Uccle since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 21,439 € and equity of 60,076 €; its revenue is not published. Its solvency stands at 91.4%, above the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Bossiroy Pharma
Companies in the same business, of comparable size and area, outside its group.
- Smilla Retail sale of pharmaceutical products Heers · balance sheet 70,168 €
- Farmecha Services Retail sale of pharmaceutical products Bornem · balance sheet 72,929 €
- ELI Retail sale of pharmaceutical products Genk · balance sheet 53,448 €
- Laphare Retail sale of pharmaceutical products Mettet · balance sheet 49,090 €
- ES Pharma Retail sale of pharmaceutical products Mol · balance sheet 84,690 €
- Caroline Vandierendonck Retail sale of pharmaceutical products Bree · balance sheet 115,934 €
- Charlie Retail sale of pharmaceutical products Retie · balance sheet 106,397 €
- Pharmanatuur Retail sale of pharmaceutical products Affligem · balance sheet 51,561 €
Frequently asked questions about Bossiroy Pharma
What is the revenue of Bossiroy Pharma?
Bossiroy Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bossiroy Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1004722733 for Bossiroy Pharma, if the company is VAT-registered. Its company number (CBE) is 1004.722.733.
Where is the registered office of Bossiroy Pharma?
According to the CBE register, the registered office of Bossiroy Pharma is in 1180 Uccle.
What is the equity of Bossiroy Pharma?
At the close of the 2025 financial year, the equity of Bossiroy Pharma amounts to 60,076 €, a solvency of 91.4% of total assets.
Who manages Bossiroy Pharma?
The register lists 1 active mandates at Bossiroy Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bossiroy Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →